Navigation Links
Researcher receives lectureship for lifetime achievements
Date:4/4/2011

Cleveland Clinic biochemist George R. Stark, Ph.D., has been awarded the American Society for Biochemistry and Molecular Biology's (ASBMB) 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship.

Stark is the Distinguished Scientist of Cleveland Clinic's Lerner Research Institute and Emeritus Professor of Genetics at Case Western Reserve University.

"George Stark has been a leader and pioneer in basic and applied research," said Charles E. Samuel, Ph.D., the C.A. Storke II Professor of biochemistry and virology at the University of California, Santa Barbara, and longtime colleague of Stark. "He has been a superb scientist personifying many of the characteristics of Herb Tabor. Recognition with our Society's Herbert Tabor Lectureship is a most fitting tribute to Stark's numerous seminal contributions."

The lectureship recognizes outstanding lifetime scientific achievements and was established to honor the many contributions of Dr. Herbert Tabor to both the ASBMB and the Journal of Biological Chemistry, where he has served as editor for nearly 40 years. Stark will be the eighth person so honored, joining previous recipients, which include a Nobel Laureate.

Stark said, "It is wonderfully gratifying to be recognized by one's peers, and it is a special privilege to be associated in this way with Herb Tabor and the previous Tabor lecturers."

Stark's contributions span many fields, influencing the understanding not only of basic biochemistry, but also gene regulation and cell signaling, having implications regarding immunity and cancer. These discoveries began during his early work on enzyme mechanisms and protein chemistry, where he developed the well known Northern and Western techniques, which detect specific nucleic acids and proteins, respectively. These techniques are now used worldwide by scientists in research, as well as in clinical testing applications. More recently, Stark is attributed with co-discovering gene amplification in mammalian cells and the Jak-Stat signaling cascade, a major pathway mediating cellular responses to signals sent by the immune system.

A native of New York City, Stark earned his Ph.D. in chemistry from Columbia University in 1959. He then served as a research associate and assistant professor at Rockefeller University with biochemists and Nobel laureates William Stein and Stanford Moore. After moving to Stanford University in 1963, he became a full professor of biochemistry in 1971. From 1983 to 1992, he worked at the Imperial Cancer Research Fund in London (now Cancer Research UK) as a senior scientist and later associate director of research. In 1992, he relocated to Cleveland Clinic, where he served as Chair of the Lerner Research Institute until 2002, and where he continues his research today.

Stark will present his award lecture at ASBMB's annual meeting's opening session on Saturday, April 9, 2011, in Washington, D.C.


'/>"/>

Contact: Dan Doron
dorond@ccf.org
216-312-0428
Lerner Research Institute
Source:Eurekalert

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. NC State researchers get to root of parasite genome
3. Researchers find animal with ability to survive climate change
4. Researchers find an essential gene for forming ears of corn
5. Researchers note differences between people and animals on calorie restriction
6. Researcher working on destruction of chemical weapons
7. Researchers study acoustic communication in deep-sea fish
8. Researchers discover that growing up too fast may mean dying young in honey bees
9. Researchers study how pistachios may improve heart health
10. UI researchers find potentially toxic substance present in Chicago air
11. Researchers develop new self-training gene prediction program for fungi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology: